Osteoporosis causes approximately 500,000 fractures annually in the UK, costing the NHS over 4.4 billion pounds per year and producing a level of disability and mortality whose scale is poorly appreciated relative to the conditions that generate more public attention. In the UK, a 50-year-old woman has a 50 percent lifetime risk of an osteoporotic fracture. Hip fracture mortality has been discussed in the context of falls: one-year mortality rates of 20 to 30 percent in adults over 75 are consistent across multiple large studies. Vertebral fractures, which are often silent, produce progressive height loss, kyphotic posture, and chronic back pain that significantly reduces quality of life over decades. Wrist fractures in the 50s and 60s are the first indication in many women that their bone density has fallen below safe thresholds. All of this is substantially preventable with early detection and targeted intervention in the decade before fractures occur, which is what the bone health component of the Longevity MOT addresses.
Why Bone Density Declines and What Accelerates It
Bone mineral density peaks in the mid-20s and begins to decline slowly thereafter, with the rate of decline accelerating significantly at menopause in women due to the loss of oestrogen's bone-protective effects. In men, bone density decline is more gradual, driven primarily by declining testosterone from the 5th decade. The primary modifiable drivers of accelerated bone loss include inadequate dietary calcium and vitamin D, physical inactivity particularly the absence of impact-loading exercise that stimulates osteoblast activity, smoking, excess alcohol, low body weight, long-term corticosteroid use, and secondary conditions including coeliac disease, inflammatory bowel disease, and thyroid dysfunction that impair nutrient absorption or directly affect bone metabolism.
The relationship between muscle and bone is particularly important: the mechanical forces exerted on bone by muscular contraction and impact loading are the primary stimulus for bone mineral deposition through osteoblast activation. The sarcopenia discussed throughout this article series therefore contributes directly to osteoporosis progression, because the reducing muscle mass produces progressively less mechanical loading on the bones it attaches to. This bidirectional relationship, sometimes called the muscle-bone unit, means that the same interventions that preserve muscle mass, particularly resistance training, are also among the most effective available for bone health, making them an integrated rather than separate priority in the Longevity MOT.
Assessment: FRAX, DEXA, and What Each Tells You
FRAX is a validated fracture risk assessment tool that calculates the 10-year probability of a major osteoporotic fracture and hip fracture from a combination of clinical risk factors including age, sex, BMI, family history of hip fracture, personal history of fracture, smoking, alcohol consumption, corticosteroid use, and presence of secondary osteoporosis conditions. It can be used with or without bone mineral density measurement, and is the primary fracture risk screening tool recommended by NICE and the Royal Osteoporosis Society for adults in primary care. Scores above intervention threshold levels indicate that treatment, typically bisphosphonates, is warranted regardless of bone density measurement.
Dual-energy X-ray absorptiometry, or DEXA, directly measures bone mineral density at the lumbar spine and femoral neck and expresses the result as a T-score, comparing the individual's bone mineral density with the mean peak bone mass of a young adult reference population. A T-score between minus 1.0 and minus 2.5 indicates osteopenia, and a T-score below minus 2.5 indicates osteoporosis. DEXA is the gold standard for bone density measurement and provides quantitative data on the rate of bone loss over successive scans spaced two years apart, allowing the response to intervention to be objectively monitored. The Longevity MOT uses FRAX to identify candidates for DEXA referral and, where available, can arrange DEXA scanning directly to include bone mineral density as a formal component of the comprehensive assessment.
Frailty Assessment: Measuring Physical Reserve
Frailty is a clinical syndrome characterised by reduced physiological reserve and increased vulnerability to stressors, producing poor outcomes after relatively minor challenges such as minor infections, elective surgery, or medication changes that a non-frail individual would handle without consequence. The Clinical Frailty Scale developed by Rockwood and colleagues classifies individuals from 1 (very fit) to 9 (terminally ill), and has been shown to predict hospitalisation, falls, and mortality independently of age and conventional comorbidity measures. The Fried Frailty Phenotype, based on five components including weight loss, exhaustion, low physical activity, slow gait speed, and weak grip strength, defines frailty by the presence of three or more components and pre-frailty by one or two.
The short physical performance battery, combining standing balance, gait speed, and chair stand tests, provides a validated composite functional measure that identifies early functional impairment before clinical frailty is established. The timed up-and-go test, measuring the time taken to rise from a chair, walk three metres, turn, return, and sit, is simple to administer and validated as a falls risk and functional decline predictor. Both tests are included in the Longevity MOT at Zhen Wellness on the Isle of Man as part of the musculoskeletal and frailty assessment domain, providing the data needed to identify pre-frailty at the stage where targeted intervention most effectively prevents progression to established frailty.
Intervening Before the Fracture: What Moves the Needle
The interventions with the best evidence for improving bone density and reducing fracture risk include progressive resistance training and impact loading exercise, calcium and vitamin D optimisation, smoking cessation, alcohol moderation, and pharmacological treatment with bisphosphonates or other bone-active agents in those with sufficiently elevated fracture risk. For adults on the Isle of Man identified by the Longevity MOT as having elevated fracture risk or osteopenic bone density, the Longevity MOT programme includes specific recommendations for resistance exercise targeting bone health, personalised nutritional guidance for calcium, vitamin D, protein, and magnesium, and referral to the GP for consideration of pharmacological management where FRAX scores are above intervention threshold.
The interaction between muscle preservation and bone health means that the EMS and resistance training programmes provided through the Zhen Wellness muscle preservation pathway simultaneously address bone health, providing the mechanical loading stimulus that maintains bone mineral density without requiring separate bone-specific exercise programmes. Adults who address both sarcopenia and bone health through an integrated resistance training, EMS, and nutrition programme are addressing the majority of the modifiable factors for both conditions in a single coherent programme rather than managing them as separate issues.
- Osteoporosis causes 500,000 fractures annually in the UK; 50-year-old women have a 50% lifetime fracture risk
- Muscle and bone form an integrated unit; sarcopenia accelerates bone density loss by reducing mechanical loading
- FRAX calculates 10-year fracture probability from clinical risk factors; DEXA directly measures bone mineral density
- The Short Physical Performance Battery and Timed Up-and-Go test quantify frailty and functional decline risk
- Pre-frailty identified by 1-2 Fried criteria; intervention at this stage most effectively prevents frailty progression
- Resistance training provides both muscle preservation and the mechanical loading stimulus for bone mineral maintenance
- Calcium, vitamin D, protein, and magnesium are the primary nutritional interventions for bone health
Sources
- Cruz-Jentoft, A.J., et al. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16-31.
- Kanis, J.A., et al. (2008). FRAX and the assessment of fracture probability in men and women from the UK. Osteoporosis International, 19(4), 385-397.
- Rockwood, K., et al. (2005). A global clinical measure of fitness and frailty in elderly people. CMAJ, 173(5), 489-495.
- Fried, L.P., et al. (2001). Frailty in older adults: evidence for a phenotype. Journals of Gerontology: Medical Sciences, 56(3), M146-M156.
- Sherrington, C., et al. (2019). Exercise for preventing falls in older people living in the community. Cochrane Database of Systematic Reviews, (1), CD012424.